Upper GI Bleed Management for NEET PG — Complete Guide 2026
Master upper GI bleed for NEET PG 2026: variceal vs non-variceal causes, Glasgow-Blatchford and Rockall scoring, Forrest classification, endoscopic therapy, TIPS indications, octreotide, PPI, and H. pylori eradication.
NEETPGAI EditorialPublished 10 Feb 202618 min read
Share this article
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Ready to put this into practice?
Start practicing NEET PG MCQs with AI-powered explanations.
Resuscitation — 2 large-bore IVs, crystalloid, restrictive transfusion Hb 7–9 g/dL (Villanueva NEJM 2013), type and cross-match, NPO, HDU monitoring
Pharmacology — IV PPI (pantoprazole 80 mg bolus → 8 mg/h) for suspected non-variceal; IV octreotide/terlipressin + ceftriaxone for suspected variceal, started before endoscopy
Endoscopy timing — within 24 h non-variceal; within 12 h variceal or unstable
Forrest classification — Ia spurting, Ib oozing, IIa visible vessel, IIb adherent clot (all high-risk → endoscopic therapy + IV PPI); IIc pigmented spot, III clean base (low-risk)
Endoscopic therapy — combination (injection + thermal or clip) for non-variceal; band ligation preferred for esophageal varices; cyanoacrylate glue for gastric varices
TIPS — rescue after failed EBL; early TIPS within 72 h for Child B active-bleeding or Child C (Baveno VII)
Secondary prevention — H. pylori test-and-treat (bismuth quadruple first-line in India), stop NSAIDs, beta-blocker ± EBL for variceal
Upper GI bleed is a common NEET PG vignette — the alcoholic with hematemesis, the elderly patient on NSAIDs with melena, the cirrhotic with massive variceal bleed — and the correct first move (octreotide vs PPI, EBL vs clip, FFP vs platelets) separates marks. This guide covers initial resuscitation, risk scoring, endoscopic therapy, TIPS decision-making, and H. pylori eradication. Pair with the medicine subject hub, the medicine high-yield topics overview, and the COPD exacerbation clinical case for critical-care integration.
Definition and epidemiology
Upper GI bleed (UGIB) is bleeding originating proximal to the ligament of Treitz — from the esophagus, stomach, or duodenum — presenting with hematemesis, coffee-ground vomitus, melena, or (if brisk) hematochezia.
Epidemiology (Indian and global):
Incidence: 50–150 per 100,000 adults per year
Male-to-female ratio 2:1
Peptic ulcer disease remains the single most common cause globally (~50%)
Variceal bleed accounts for ~10–30% in centres caring for cirrhosis-heavy populations (high in India due to alcohol and chronic hepatitis B/C)
Mortality: 2–10% non-variceal; up to 20–30% variceal
NSAID use, H. pylori, alcohol, and cirrhosis are the dominant risk factors
Clinical presentation:
Hematemesis — fresh blood (brisk, usually proximal) or coffee-ground vomitus (oxidised haem, slower bleed)
Melena — black, tarry, foul-smelling stool; requires ~50–100 mL blood in stomach for >=4 h
Hematochezia — bright red rectal blood; in UGIB implies brisk bleed (>1000 mL) or rapid transit
Haemodynamic features — tachycardia (early), hypotension, syncope, shock
Upper GI bleed causes split into two decision-changing buckets: non-variceal (most common) and variceal (cirrhosis-related) — because initial pharmacological therapy differs.
Non-variceal causes:
Cause
Frequency
Key features
Peptic ulcer disease
~50%
Duodenal > gastric; NSAIDs, H. pylori, steroids, stress
Initial management of upper GI bleed prioritises airway, fluid resuscitation, transfusion, and early empirical pharmacotherapy — before endoscopy confirms the source.
Step-by-step resuscitation:
Airway — intubate if altered sensorium, massive hematemesis with aspiration risk, or active variceal bleed with anticipated EUGD
24 h max; complications — aspiration, esophageal necrosis; inflate gastric balloon first, then esophageal at 30–45 mmHg
Self-expanding metallic stent (Danis stent)
Rescue bridge, better than balloon tamponade
Up to 7 d
Forrest classification and rebleeding prediction
Forrest classification describes endoscopic appearance of a peptic ulcer and predicts 30-day rebleeding risk — it guides endoscopic therapy and duration of PPI infusion.
Forrest class
Description
Rebleed risk
Management
Ia
Spurting arterial bleed
~55%
Endoscopic therapy + IV PPI × 72 h
Ib
Oozing bleed
~55%
Endoscopic therapy + IV PPI × 72 h
IIa
Non-bleeding visible vessel (NBVV)
~43%
Endoscopic therapy + IV PPI × 72 h
IIb
Adherent clot
~22%
Clot removal and assess; therapy if stigmata; IV PPI × 72 h
IIc
Flat pigmented spot
~10%
No therapy; oral PPI; early feeding
III
Clean ulcer base
<5%
No therapy; oral PPI; discharge
Forrest I–IIb = high-risk → endoscopic therapy + admission + IV PPI 72 h.
Forrest IIc–III = low-risk → oral PPI, early refeeding, consider early discharge.
Post-endoscopy disposition:
High-risk → HDU 24 h; clear fluids after 6 h; step down to oral PPI after 72 h
Rebleed (recurrent hematemesis, drop in Hb >=2 g/dL, haemodynamic instability) → repeat endoscopy; if fails → interventional radiology embolisation or surgery (oversewing, pyloroplasty)
TIPS and secondary prevention of variceal bleed
TIPS (Transjugular Intrahepatic Portosystemic Shunt) reduces portal pressure by creating a communication between a hepatic vein and a portal vein branch through a stent — it is used as rescue after failed EBL and as early pre-emptive therapy in high-risk variceal bleed.
TIPS indications (Baveno VII 2022):
Rescue TIPS — failure to control bleed despite optimal EBL + vasoactive drugs (persistent bleed at 24 h or rebleed within 5 days)
Pre-emptive (early) TIPS within 72 h — high-risk variceal bleed: Child-Pugh C (10–13) OR Child-Pugh B with active bleeding on endoscopy
Refractory ascites (not responding to diuretics + paracentesis)
Hepatic hydrothorax refractory to medical management
TIPS contraindications:
Absolute: right heart failure, severe pulmonary hypertension, polycystic liver disease, biliary obstruction
Relative: Child-Pugh >13 with MELD >30 (no survival benefit), severe hepatic encephalopathy, hepatocellular carcinoma in TIPS track
Propranolol titrated to max tolerated dose or HR 55–60; or carvedilol 6.25–12.5 mg/day (preferred — added alpha-1 effect); nadolol alternative
Endoscopic band ligation
Every 2–4 weeks until obliteration, then surveillance
Combination
NSBB + EBL superior to either alone for secondary prophylaxis
TIPS
Refractory rebleed despite NSBB + EBL
Liver transplantation
Decompensated cirrhosis, MELD >=15
Primary prophylaxis (no prior bleed, varices on screening endoscopy):
Small varices (<5 mm) with red wale signs OR Child C → NSBB
Medium/large varices (>5 mm) → NSBB OR EBL (equivalent; NSBB preferred for lower cost/availability)
Carvedilol preferred NSBB — also effective in compensated cirrhosis with clinically significant portal hypertension (HVPG >=10)
H. pylori eradication for PUD
H. pylori is the primary reversible cause of peptic ulcer disease — eradication after a bleeding ulcer reduces 1-year recurrence from 20–40% to <5%.
Testing:
Rapid urease test / histology / culture at index endoscopy (PPI must be stopped 2 weeks prior for accuracy — in acute bleed, test even on PPI and confirm later with UBT)
Urea breath test (UBT) and stool antigen test (SAT) are non-invasive — best for confirming eradication ≥4 weeks after therapy and ≥2 weeks off PPI
Serology has poor specificity (can't distinguish active from past infection); not used for diagnosis or eradication confirmation
First-line regimens (14 days):
Regimen
Composition
Use
Bismuth quadruple
PPI BD + bismuth subsalicylate 525 mg QID + tetracycline 500 mg QID + metronidazole 500 mg TID
Preferred in India (high clarithromycin resistance)
Concomitant
PPI BD + amoxicillin 1 g BD + clarithromycin 500 mg BD + metronidazole 500 mg BD
Alternative
Clarithromycin triple
PPI BD + amoxicillin 1 g BD + clarithromycin 500 mg BD
Only if clarithromycin resistance <15% locally — uncommon in India
Post-bleed specifics:
Start eradication regimen once oral intake tolerated
Continue PPI × 4–8 weeks beyond eradication to heal ulcer
Confirm eradication 4 weeks after regimen and 2 weeks off PPI (UBT or SAT)
Discontinue NSAIDs permanently if possible; if needed, add maintenance PPI and/or switch to COX-2 selective (celecoxib)
Special situations:
Gastric ulcer — always repeat endoscopy at 8–12 weeks to confirm healing and exclude malignancy
NSAID-associated ulcer — stop NSAID; H. pylori test-and-treat; PPI continued
Refractory ulcer (unhealed at 12 weeks) — compliance, persistent H. pylori, occult NSAID use, Zollinger-Ellison, malignancy
Sources and references
Harrison's Principles of Internal Medicine, 21st Edition (Loscalzo, Fauci, Kasper, Hauser, Longo, Jameson, Eds., 2022) — Chapter on Gastrointestinal Bleeding.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 11th Edition (Feldman, Friedman, Brandt, Eds., 2020) — Chapters on upper GI bleeding and portal hypertension.
Laine L, Barkun AN, Saltzman JR, et al. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol 2021; 116:899-917.
de Franchis R et al. Baveno VII — Renewing consensus in portal hypertension. J Hepatol 2022; 76:959-974.
Villanueva C et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368:11-21.
Lau JYW et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 2007; 356:1631-1640.
Frequently asked questions
How many upper GI bleed questions appear in NEET PG?
Upper GI bleed and its management contribute 2-3 direct questions per NEET PG paper across medicine, gastroenterology and surgery papers. The most tested subtopics are Forrest classification, Glasgow-Blatchford score cutoffs, variceal vs non-variceal initial management, TIPS indications, and Mallory-Weiss tear features based on 2019-2025 pattern analysis.
What is the initial resuscitation for upper GI bleed?
Initial resuscitation follows the ABC approach. Two large-bore IV cannulae (16-18 G), crystalloid bolus (1 L Ringer lactate), type and cross-match 2 units PRBC, target hemoglobin 7-9 g/dL (restrictive transfusion — Villanueva NEJM 2013). Start IV PPI (pantoprazole 80 mg bolus then 8 mg/h infusion) in suspected non-variceal; add IV octreotide 50 mcg bolus then 50 mcg/h or terlipressin 2 mg every 4 h plus prophylactic ceftriaxone 1 g in suspected variceal bleed. NPO, monitor in HDU. Urgent endoscopy within 24 h (within 12 h for variceal).
What is the Forrest classification?
Forrest classification describes endoscopic appearance of peptic ulcers and predicts rebleeding risk. Forrest Ia active spurting bleed — 55 percent rebleed, high mortality. Forrest Ib active oozing — 55 percent rebleed. Forrest IIa non-bleeding visible vessel — 43 percent rebleed. Forrest IIb adherent clot — 22 percent rebleed. Forrest IIc flat pigmented spot — 10 percent rebleed. Forrest III clean ulcer base — less than 5 percent rebleed. Forrest Ia, Ib, IIa, IIb are high risk and require endoscopic therapy plus IV PPI; Forrest IIc and III are low risk and discharge-ready.
What is the Glasgow-Blatchford score?
Glasgow-Blatchford score (GBS) is a pre-endoscopy risk score using blood urea, hemoglobin, systolic BP, heart rate, melena, syncope, hepatic disease, cardiac failure. Score 0 identifies very low-risk patients eligible for outpatient management. Score greater than or equal to 1 typically warrants admission and endoscopy. Unlike Rockall, it does NOT require endoscopy findings. Validated in NEJM 2000 (Blatchford) and now preferred over clinical Rockall for triage.
What is the Rockall score?
Rockall score has two versions. Clinical (pre-endoscopy) Rockall uses age, shock (HR, SBP), comorbidity — score 0-7. Complete (post-endoscopy) Rockall adds diagnosis and stigmata of recent hemorrhage — score 0-11. Score less than or equal to 2 is low-risk (less than 5 percent rebleed, less than 1 percent mortality). Score greater than or equal to 8 is high-risk (more than 40 percent mortality). Guides decisions on admission level, endoscopy timing, and discharge.
When is TIPS indicated in variceal bleed?
TIPS (Transjugular Intrahepatic Portosystemic Shunt) is indicated as rescue therapy when endoscopic band ligation fails to control variceal bleed, or for refractory/recurrent bleed. Baveno VII consensus recommends early (pre-emptive) TIPS within 72 h in high-risk variceal bleed (Child-Pugh B with active bleeding on endoscopy, or Child-Pugh C up to 13). Contraindications include Child-Pugh greater than 13 with MELD greater than 30 (no survival benefit), severe hepatic encephalopathy, heart failure, pulmonary hypertension. Child-Turcotte-Pugh C with MELD greater than or equal to 19 may still benefit from TIPS as a bridge to transplant.
What is the role of octreotide in variceal bleed?
Octreotide is a somatostatin analogue that reduces splanchnic blood flow and portal pressure. Dose is 50 mcg IV bolus followed by 50 mcg/h infusion for 3-5 days. Equally effective as terlipressin and vasopressin plus nitroglycerin but better safety profile. Start as soon as variceal bleed is suspected — before endoscopic diagnosis. Reduces rebleeding but modest mortality benefit. Terlipressin is the only vasoactive drug shown to reduce mortality in variceal bleed (meta-analysis) and is preferred where available.
How is H. pylori treated after a bleeding peptic ulcer?
H. pylori eradication after a bleeding peptic ulcer reduces recurrence from 20-40 percent at 1 year to less than 5 percent. Standard triple therapy is PPI plus clarithromycin 500 mg BD plus amoxicillin 1 g BD for 14 days (avoid in areas with clarithromycin resistance greater than 15 percent). Bismuth-based quadruple therapy (PPI plus bismuth plus tetracycline plus metronidazole for 14 days) is preferred first-line in India given high clarithromycin resistance. Test for eradication with urea breath test or stool antigen at least 4 weeks after therapy completion.
What is the difference between variceal and non-variceal bleed management?
Variceal bleed requires IV octreotide/terlipressin plus prophylactic ceftriaxone plus endoscopic band ligation (EBL, preferred over sclerotherapy) within 12 h. Beta-blocker (propranolol/carvedilol/nadolol) is started after bleed control for secondary prophylaxis. Non-variceal bleed (usually PUD) requires high-dose IV PPI plus endoscopic therapy (injection plus thermal/clip — combination is superior to single modality) within 24 h. Test and treat H. pylori. Discontinue NSAIDs. Restrictive transfusion strategy (Hb 7-9 g/dL) applies to both.
What is the Mallory-Weiss tear?
Mallory-Weiss tear is a longitudinal mucosal laceration at the gastroesophageal junction caused by forceful retching or vomiting. Classic history is repeated vomiting followed by hematemesis in an alcoholic or pregnant patient with hyperemesis gravidarum. Most heal spontaneously within 48-72 h with conservative management (PPI, antiemetics). Endoscopic therapy (injection, clip, band) is indicated for active bleeding. Boerhaave syndrome is the feared differential — full-thickness esophageal rupture with pneumomediastinum and surgical emergency.
Explore our pricing plans for unlimited practice across all 19 subjects, AI-powered doubt resolution, and personalized study plans.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Written by: NEETPGAI Editorial Team
Reviewed by: Pending SME Review
Last reviewed: February 2026
This article is reviewed by qualified medical professionals for clinical accuracy and exam relevance. For corrections or updates, contact the editorial team.
